Print this page

Eliahu S. Feen, M.D.

Eliahu S. Feen, M.D.
Associate Professor
Director of Vascular Neurology Fellowship
Department of Neurology & Psychiatry



1438 S. Grand Blvd.
St. Louis, MO 63104



Medical School:
Doctor of Medicine
University of Maryland School of Medicine
August 1996 – May 2000

Postgraduate Training:
Medical Intern
Union Memorial Hospital
July 2000 – July 2001

Residency:
Neurology Residency
Case Western School of Medicine
July 2001-June 2004

Fellowship:
Stroke Neurology & Neurointensive Care Fellowship
Case Western School of Medicine
July 2004 – July 2006

Board Certification:
American Board of Psychiatry & Neurology
Primary Certification: Neurology Certified 2006

Subspecialty Certification: Neurocritical Care
Certified 2007

Subspecialty Certification: Vascular Neurology
Certified 2009

Abstracts:
Pope H, Anger B, Malmstrom T, Feen E. Evaluation of ACE Inhibitor Use and Prevention of Pneumonia in Stroke Patients. 10th Annual Neurocritical Care Conference (International), October 4-7, 2012. (Denver, CO).

Garavaglia J, Anger B, Christopher K, Feen E, Cruz-Flores S. Venous Thromboembolism Risk in Spontaneous Intracerebral Hemorrhage. 9th Annual Neurocritical Care Conference (International), September 21-24, 2011. (Montreal, Quebec, Canada).

Kitchener JM, Jumaa M, Kale S, Alshekhlee A, Kaushal R, Chaisam T, Chibnall J, Acharya A, Piriyawat P, Feen E, Cruz-Flores S, Callison RC, Edgell R, Jovin T, Vora N. Imaging criteria as a surrogate marker for outcomes after intra-arterial thrombolysis. 35th Annual International Stroke Conference, February 9-11, 2011. (Los Angeles, CA).

Kaushal R, Edgell R, Vora R, Callison RC, Feen E, Piriyawat P, Acharya A, Cruz-Flores S. The internal maxillary artery is the key external to internal carotid collateral in carotid occlusion. 35th Annual International Stroke Conference, February 9-11, 2011. (Los Angeles, CA).

Alshekhlee A, Kitchener JM, Kale S, Feen E, Piriyawat P, Callison RC, Edgell R, Vora N, Cruz-Flores S. The risk of thrombolysis in demented population: A case control study. 35th Annual International Stroke Conference, February 9-11, 2011. (Los Angeles, CA).

Zaidi S, Hacke A, Chen S, Kaushal R, Alshekhlee A, Kitchener JM, Kale S, Chaisam T, Chibnall J, Acharya A, Piriyawat P, Feen E, Cruz-Flores S, Callison RC, Edgell R, Vora N. Statin use may increase the risk of symptomatic hemorrhage after intravenous thrombolysis. 35th Annual International Stroke Conference, February 9-11, 2011. (Los Angeles, CA).

Daoud AAG, Acharya AB, Edgell R, Feen E, Piriyawat P, Vora N, Cruz-Flores S. Factor VII for intracerebral hemorrhage: a systematic review and meta-analysis. 62nd American Academy of Neurology Annual Meeting. April 10-17, 2010 (Toronto, CA).

Kitchener JM, Hake A, Vora N, Edgell R, Cruz-Flores S, Piriyawat P, Feen E, Acharya AB, Chibnall J, Chaisam T, Kale S, Mayotarn S, Daoud A, Holzemer E, Severine J. Concomitant anterior circulation infarction and age correlate with clinical outcome in posterior circulation strokes. 62nd American Academy of Neurology Annual Meeting. April 10-17, 2010 (Toronto, CA).

Edgell RC, Kale S, Vora N, Piriywat P, Feen E, Cruz-Flores S. Lower Incidence Of Symptomatic And Asymptomatic Vasospasm In Elderly Aneurysmal Subarachnoid Hemorrhage Patients. 34th Annual International Stroke Conference, February 24-26, 2010. (San Antonio, TX).

Kumar N, Edgell RC, Piriyawat P, Vora N, Feen E, Acharya A, Cruz-Flores S. Vertebral artery origin disease: A neglected cause of posterior circulation stroke and TIA. 33rd Annual Meeting of the American Society of Neuroimaging, January 14-17, 2010. (San Francisco, CA).

Grand Rounds and Institutional Presentations:
Moderator, “Intracranial Stenting: the Debate Continues”, 5th Annual Advances in Stroke Care, Saint Louis University Stroke Symposium 2012, St. Louis, 09/2012.

“Topics in Stroke”, St. Louis Regional Combined Emergency Medicine Conference on Current Concepts in Neurology, Barnes-Jewish Hospital, St. Louis, 09/2012.

“Ethical problems created by new technologies: focus on Neurology”, Maimonides Society of Jewish Federation of St. Louis, Lecture at Missouri Baptist Hospital, St. Louis, 07/2011.

“Medical aspects of brain death”, Center for Adult Jewish Education and Melton mini-school lecture series, 04/2011.

“Medical futility”, Grand Rounds for Department of Medicine, John Cochrane Veterans Affairs Medical Center, St. Louis, MO, 04/2011.

“Preserving the Donation Opportunity: the MTS Clinical Bundle” and “Brain Death Determination”, Mid-America Transplant Services, Saint Louis University, Department of Neurology & Psychiatry Dinner Meeting, St. Louis, 01/2011.

“Sleep disorders and Stroke”, 8th Annual Updates in Sleep Medicine, St. Louis, MO, 10/2010.

“Neurointensive Care Management in Acute Stroke”, Neurosciences symposium of St. Louis University Hospital, Springfield, MO, 03/2010.

“Hypothermia and cardiac arrest”, Saint Francis Medical Center evening program, Cape Girardeau, MO, 01/2010.

Research:
Sub-investigator for the following on-going and recently closed clinical trials:
Human Albumin Therapy for Nerve protection in Stroke (ALIAS)
Clot Lysis to Resolve Brain Hemorrhage (CLEAR-IVH)
Prevention of Small Subcortical Strokes (SPS3)
Insulin Resistance Intervention (ISIS)
MR and Recanalization of Stroke Clots Using Embolectomy (MR-RESCUE), an NINDS-sponsored clinical trial

Site Principal Investigator for:
A Randomized Multicenter Clinical Trail of Unruptured Brain AVMs (ARUBA), an NINDS-sponsored trial (trial now closed at Saint Louis University)

Sub-investigator for clinical trials previously conducted at Saint Louis University:
NeuroFlo Treatment in Ischemic Stroke (SENTIS CoAxia study)
Hypothermia for Acute Stroke (ICTUS-L)
Ancrod (ViprinexTM) in Subjects Beginning Treatment within 6 Hours of the Onset
of Acute, Ischemic Stroke (ANCROD)
Antihypertensive Treatment in Acute Brain Hemorrhage (ATACH)
NeuroThera ® Laser System within 24 hours from stroke onset (NEST II or Photothera)
Ultrasound Administration for Stroke (TUCSON)